Ozempic – GLP-1 Treatment for Type 2 Diabetes Management & Weight Control Support

Ozempic is a GLP-1 receptor agonist developed by Novo Nordisk, designed to help adults manage type 2 diabetes by improving blood sugar control and supporting metabolic health. This once-weekly injectable treatment works by regulating insulin levels, reducing appetite, and supporting overall glucose